Kent Thoelke is Executive Vice President, Scientific and Medical Affairs, Safety and Commercialization Services. He oversees scientific and strategic product development to empower project teams and promote the success of clients’ studies. He has over 21 years of experience in the global drug development, diagnostic and device industries, offering specialized expertise in hematology/oncology studies. Having visited over 40 countries, he is familiar with the global drug development environment, and he has established relationships with therapeutic experts in numerous indications around the world. Mr. Thoelke has spoken widely regarding the current landscape of clinical trial recruitment and drug development timelines. A leader in the field of Medical Informatics, Mr. Thoelke focuses on leveraging data to maximize patient enrollment by selecting high-performing sites to minimize overall drug development timelines.
[Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.]
Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.